Recent federal import changes are raising questions about prescription access and sourcing options. SHARx CEO Corey Durbin says the company’s new Stormproof program is designed to help employers and members navigate uncertainty through expanded sourcing flexibility, prescription advocacy, and additional healthcare support.
ST. LOUIS, Nov. 19, 2026 /PRNewswire/ — Recent media coverage and evolving federal import requirements have drawn renewed attention to prescription sourcing and continuity of access. The news, changing policies, and shifting implementation deadlines have prompted questions from employers and benefits brokers about their sourcing options. The industry experts at SHARx, a supply-chain and procurement management company, have answers.
“Employers and brokers are right to ask what these developments mean for the people who rely on prescriptions, especially high-priced specialty pharmaceuticals,” said Corey Durbin, Chief Executive Officer and Co-founder of SHARx. “But the problem is getting worse as high-cost drugs (those that cost more than $4,000 per year) spending has doubled what it was in 2017. Our response has been in development for months.”
Stormproof emanated from a full review of all member medications. The increase in domestic sourcing options has made the inception of Stormproof possible and will shield employers and members from sourcing uncertainty.
“Stormproof is built around a full analysis of the domestic options and a determination that the value we bring to members and employers can be even greater than it has been. It gives our organization more ways to help members access the medications they need as sourcing conditions change. In this business, the operating conditions can change like the weather. It’s an atmosphere that has always driven us to be a highly responsive organization,” Durbin said.
Preparing for Changing Requirements
Recent headlines, including a November 11, 2026, CNBC report detailing a federal arrest of a top healthcare company official accused of illegal drug importation through an alternative funding program (AFP), come on the heels of Federal agencies announcing changes affecting customs procedures. First, a U.S. Customs and Border Protection (CBP) rule established new requirements for foreign importers of record, the parties legally responsible for declaring imported goods to CBP, takes effect January 5, 2027. Separately, CBP moved the mandatory implementation date for its Entry Type 13 process, an electronic filing process for certain international mail shipments, from October 22, 2026, to January 20, 2027.
The requirements address different customs processes. Their specific effects on individual prescription pathways may depend on how a shipment is handled and on applicable agency requirements. Durbin said SHARx’s policy and operations teams have been preparing for the changes and evaluating options to help members maintain access to their medications while minimizing potential disruptions.
“Policy changes create uncertainty for all stakeholders, but the need for affordable specialty medication is not going away,” said Paul Pruitt, Chief Growth Officer and Co-founder of SHARx. “Our role is to understand what is changing, help employers and members assess their options, and keep working on ways to support both.”
A Flexible Approach to Prescription Access
Stormproof is designed to support members with affordable options, depending on the member or employer preference, member circumstances, and applicable requirements. Durbin says SHARx is still committed to assisting members, most able to obtain their medications at no cost, regardless of sourcing pathways. Employers can choose from two different financial models – both with significant upside to the employer.
The program also includes additional member support designed to complement prescription assistance. These include AI-enhanced mental health and wellness support, 24/7 virtual primary care, and a very affordable weight-loss option that helps replace a benefit many employers had to cut out because of cost.
“Employees need affordable access but should not have to depend on a single sourcing pathway to help them manage high-cost medications,” Durbin said. “Stormproof gives us a broader framework to assist employers and members as circumstances change, while keeping affordability and access at the center of our plans.”
SHARx has worked with employer-sponsored health plans since 2017 to help address the financial impact of high-cost prescription drugs, while adhering to the highest standards of member access and support. The company says it will continue to monitor policy developments and provide clients with updates as it operationalizes Stormproof.
“Storms are part of this landscape, but too many try and run from the storm instead of through it. Stormproof reflects how we respond: stay prepared, adapt as conditions change, and keep working with employers and members to find the fastest path forward through the storm.” Durbin said.
About SHARx
SHARx is a procurement and supply chain management solution for high-cost prescription drugs. Working alongside employer-sponsored health plans, SHARx helps employers address the financial impact of expensive and specialty medications while providing members with personalized advocacy and access to cost-effective sourcing solutions. Learn more at SHARx.com.
References:
U.S. Customs and Border Protection. (2026, November 6). Heightened requirements for foreign importers of record. Federal Register, 91(214), 69977–70007. govinfo.gov/content/pkg/FR-2026-11-06/html/2026-22735.htmgovinfo.govU.S. Customs and Border Protection. (2026, October 14). International mail Entry Type 13 mandatory implementation date extended to Jan. 20, 2027 [News release]. content.govdelivery.com/accounts/USDHSCBP/bulletins/42f29b6Zamost, S. (2026, November 11). Feds arrest top official of healthcare company, alleging illegal drug importation. CNBC. cnbc.com/2026/11/11/canarx-official-arrested-drug-importation.html
Media inquiries:
Karla Jo Helms
JOTO PR™
727-777-4629
Jotopr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/increased-domestic-options-pave-way-for-new-sharx-stormproof-solution-302944912.html
SOURCE SHARx